LHC Group (LHCG) Rating Increased to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of LHC Group (NASDAQ:LHCG) from a hold rating to a buy rating in a report issued on Tuesday. The brokerage currently has $106.00 target price on the health services provider’s stock.

According to Zacks, “LHC Group, Inc. is the preferred post-acute care partner for hospitals, physicians and families nationwide. From home health and hospice care to long-term acute care and community-based services, LHC delivers high-quality, cost-effective care that empowers patients to manage their health at home. Hospitals and health systems around the country have partnered with LHC Group to deliver patient-centered care in the home. “

A number of other research analysts also recently commented on the company. Robert W. Baird increased their target price on LHC Group from $95.00 to $98.00 and gave the stock a neutral rating in a report on Friday, November 2nd. William Blair reaffirmed a buy rating on shares of LHC Group in a report on Thursday, November 1st. Craig Hallum downgraded LHC Group from a buy rating to a hold rating and reduced their target price for the stock from $99.00 to $92.00 in a report on Friday, October 26th. BidaskClub raised LHC Group from a buy rating to a strong-buy rating in a report on Friday, September 28th. Finally, Bank of America set a $119.00 target price on LHC Group and gave the stock a buy rating in a report on Tuesday, September 18th. Four analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of $105.64.

LHCG traded down $1.25 on Tuesday, reaching $95.54. The company’s stock had a trading volume of 4,612 shares, compared to its average volume of 391,368. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.61 and a current ratio of 1.61. LHC Group has a 1 year low of $58.65 and a 1 year high of $103.79. The company has a market capitalization of $2.99 billion, a P/E ratio of 39.46, a P/E/G ratio of 1.60 and a beta of 0.80.

LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, October 31st. The health services provider reported $0.95 EPS for the quarter, hitting analysts’ consensus estimates of $0.95. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. The company had revenue of $507.00 million for the quarter, compared to the consensus estimate of $515.03 million. During the same quarter last year, the business posted $0.64 EPS. LHC Group’s quarterly revenue was up 88.0% compared to the same quarter last year. As a group, equities research analysts forecast that LHC Group will post 3.52 earnings per share for the current fiscal year.

In other news, COO Donald Dwayne Stelly sold 2,756 shares of the stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $99.32, for a total transaction of $273,725.92. Following the sale, the chief operating officer now directly owns 104,512 shares in the company, valued at approximately $10,380,131.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $95.10, for a total value of $7,132,500.00. Following the sale, the chief executive officer now owns 200,765 shares in the company, valued at $19,092,751.50. The disclosure for this sale can be found here. Insiders have sold a total of 79,677 shares of company stock worth $7,587,030 over the last quarter. Insiders own 6.80% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of LHCG. PNC Financial Services Group Inc. boosted its stake in shares of LHC Group by 6.7% during the 3rd quarter. PNC Financial Services Group Inc. now owns 13,223 shares of the health services provider’s stock worth $1,362,000 after acquiring an additional 826 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of LHC Group by 2.9% during the 3rd quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock worth $75,394,000 after acquiring an additional 20,567 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of LHC Group by 283.5% during the 3rd quarter. Alliancebernstein L.P. now owns 270,086 shares of the health services provider’s stock worth $27,816,000 after acquiring an additional 199,651 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of LHC Group by 12.6% during the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,957 shares of the health services provider’s stock worth $717,000 after acquiring an additional 776 shares in the last quarter. Finally, Swiss National Bank boosted its stake in shares of LHC Group by 6.0% during the 3rd quarter. Swiss National Bank now owns 51,566 shares of the health services provider’s stock worth $5,311,000 after acquiring an additional 2,900 shares in the last quarter. Hedge funds and other institutional investors own 86.50% of the company’s stock.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Story: Asset Allocation Models, Which is Right For You?

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply